EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Mesenchymal stromal cell transplantation ameliorates fibrosis and microRNA dysregulation in skeletal muscle ischemia

Clara Sanz-Nogués iD, Alan J Keane, Michael Creane, Sean O Hynes, Xizhe Chen, Caomhán J Lyons, Emma Horan, Stephen J Elliman, Katarzyna Goljanek-Whysall, Timothy O'Brien

Stem Cells · 2024

DOI: 10.1093/stmcls/sxae058 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Stem Cells, 2024. Verfasst von Clara Sanz-Nogués und 9 weiteren Autor:innen. Beteiligte Einrichtung: Regenerative Medicine Institute (REMEDI), University of Galway, Galway, Ireland. Hauptthemen laut MEDLINE: MicroRNAs, Fibrosis, Ischemia, Muscle, Skeletal. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science Foundation of Ireland, European Regional Development Fund, Irish Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Peripheral arterial disease (PAD) is associated with lower-extremity muscle wasting. Hallmark features of PAD-associated skeletal muscle pathology include loss of skeletal muscle mass, reduced strength and physical performance, increased inflammation, fibrosis, and adipocyte infiltration. At the molecular level, skeletal muscle ischemia has also been associated with gene and microRNA (miRNA) dysregulation. Mesenchymal stromal cells (MSCs) have been shown to enhance muscle regeneration and improve muscle function in various skeletal muscle injuries. This study aimed to evaluate the effects of intramuscularly delivered human umbilical cord-derived MSCs (hUC-MSCs) on skeletal muscle ischemia. Herein, we report an hUC-MSC-mediated amelioration of ischemia-induced skeletal muscle atrophy and function via enhancement of myofiber regeneration, reduction of tissue inflammation, adipocyte accumulation, and tissue fibrosis. These changes were observed in the absence of cell-mediated enhancement of blood flow recovery as measured by laser Doppler imaging. Furthermore, reduced tissue fibrosis in the hUC-MSC-treated group was associated with upregulation of miR-1, miR-133a, and miR-29b and downregulation of targeted pro-fibrotic genes such as Col1a1 and Fn1. Our results support the use of hUC-MSCs as a novel approach to reduce fibrosis and promote skeletal muscle regeneration after ischemic injury in patients with PAD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsFibrosisIschemiaMuscle, SkeletalMesenchymal Stem Cell TransplantationMesenchymal Stem CellsHumansAnimalsMiceMaleUmbilical Cord

Stichwörter der Autor:innen

fibrosismesenchymal stromal cellsmicroRNAsmuscle ischemiaperipheral arterial disease

Substanzen

MicroRNAsMIRN133 microRNA, humanMIRN1 microRNA, human

Autor:innen und Institutionen

  • Regenerative Medicine Institute (REMEDI), University of Galway, Galway, Ireland.
  • CÚRAM SFI Research Centre for Medical Devices, University of Galway, Galway, Ireland.
  • Discipline of Pathology, University of Galway, Galway, Ireland.
  • Division of Anatomic Pathology, University Hospital Galway, Galway, Ireland.
  • Orbsen Therapeutics Ltd., Galway, Ireland.
  • Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, United Kingdom.

ORCID-Profile: Clara Sanz-Nogués

Förderung

  • Science Foundation of Ireland
  • European Regional Development Fund
  • Irish Research Council

Zitieren

APA

Sanz-Nogués, C., Keane, A. J., Creane, M., Hynes, S. O., Chen, X., Lyons, C. J., Horan, E., Elliman, S. J., Goljanek-Whysall, K., & O'Brien, T. (2024). Mesenchymal stromal cell transplantation ameliorates fibrosis and microRNA dysregulation in skeletal muscle ischemia. Stem Cells. https://doi.org/10.1093/stmcls/sxae058

Vancouver

Sanz-Nogués C, Keane AJ, Creane M, Hynes SO, Chen X, Lyons CJ, et al. Mesenchymal stromal cell transplantation ameliorates fibrosis and microRNA dysregulation in skeletal muscle ischemia. Stem Cells. 2024. doi:10.1093/stmcls/sxae058

BibTeX
@article{SanzNogus2024,
  author = {Sanz-Nogués, Clara and Keane, Alan J and Creane, Michael and Hynes, Sean O and Chen, Xizhe and Lyons, Caomhán J and Horan, Emma and Elliman, Stephen J and Goljanek-Whysall, Katarzyna and O'Brien, Timothy},
  title = {Mesenchymal stromal cell transplantation ameliorates fibrosis and microRNA dysregulation in skeletal muscle ischemia},
  journal = {Stem Cells},
  year = {2024},
  doi = {10.1093/stmcls/sxae058}
}
Kostenlos starten →